Share: Facebook Twitter LinkedIn
Activity Provided By:

Physicians’ Education Resource®, LLC.

Community Practice Connections™: Exploring the Potential Role for Gene Therapy in Hemophilia B

Access Activity

Overview / Abstract:

Target Audience
This activity is directed toward hematologists and hematologist-oncologists. Pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with hemophilia B are invited to participate.

Activity Overview
In hemophilia B, an absence of clotting factor IX leads to a failure to facilitate and stabilize the primary platelet and fibrin plug that initially forms a clot. As a result, patients experience prolonged bleeding. Despite recent improvements in its treatment options, hemophilia B continues to have a significant negative impact on patients’ health-related quality of life. Gene therapy for hemophilia B has the potential to reduce the treatment burden for patients and their care providers by eliminating the need for regular prophylaxis.

This Community Practice Connection™ program provides an in-depth review of some of the key highlights from the 2022 American Society of Hematology Annual Meeting and Exposition held in December 2022. This unique and engaging multimedia activity is ideal for the community-based clinician, and it focuses on the practical aspects the emerging gene therapy for patients with hemophilia B, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
Discuss the burden of disease for patients with hemophilia B
Outline the current standard of care for patients with hemophilia B
Assess clinical trial data for gene therapy for hemophilia B
Describe models for implementation of gene therapy for hemophilia B into clinical practice
Apply strategies to select appropriate patients for gene therapy
Review the role of the multidisciplinary team in the management of patients receiving gene therapy for hemophilia B

Expiration

Mar 31, 2024

Discipline(s)

Nursing CNE, Physician CME

Format

Online

Credits / Hours

1.5

Accreditation

ACCME;ANCC

Presenters / Authors / Faculty

Christine L. Kempton, MD, MSc
Andrew D. Leavitt, MD
Steven Pipe, MD
Annette Von Drygalski, MD, PharmD

Sponsors / Supporters / Grant Providers

CSL Behring LLC

Keywords / Search Terms

Relias LLC Relias LLC Relias, Free CME, Hemophilia B Free CE CME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map